Multiple Assemblies exist for SMTL entry 5i5k
Structure of complement C5 in complex with eculizumab; X-RAY DIFFRACTION 4.20 Å

	SMTL ID 5i5k.1 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Complement C5; Eculizumab heavy chain (variable domain); Eculizumab light chain (variable domain) Oligo-state hetero-1-1-1-mer
	SMTL ID 5i5k.2 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Polypeptides Complement C5; Eculizumab heavy chain (variable domain); Eculizumab light chain (variable domain) Oligo-state hetero-1-1-1-mer